1. Date of resolution: 2026/05/27. 2. Directors involved: Independent Director Yen Hsing-fu, Independent Director Chen Ming-yi. 3. Permitted activities: Yen Hsing-fu as Independent Director of Topco Scientific; Chen Ming-yi as Supervisor of YC Medical. 4. Duration: During the term of office. 5. Resolution result: Approved as proposed in accordance with Article 209 of the Company Act. 6. Mainland China business: Not applicable. 7. Financial impact: None. 8. Other: None.

FACT BOX

  • Source: PR Times
  • Category: corporate_governance